These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28814868)

  • 1. Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
    Paolini M; Poul L; Berjaud C; Germain M; Darmon A; Bergère M; Pottier A; Levy L; Vibert E
    Int J Nanomedicine; 2017; 12():5537-5556. PubMed ID: 28814868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
    Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
    Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles.
    Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y
    J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M; Mishra P; Jain NK
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer.
    Gupta P; Singh M; Kumar R; Belz J; Shanker R; Dwivedi PD; Sridhar S; Singh SP
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):67-69. PubMed ID: 29593398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery.
    Byagari K; Shanavas A; Rengan AK; Kundu GC; Srivastava R
    J Biomed Nanotechnol; 2014 Jan; 10(1):109-19. PubMed ID: 24724503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells.
    Shi W; Yuan Y; Chu M; Zhao S; Song Q; Mu X; Xu S; Zhang Z; Yang K
    J Biomater Appl; 2016 Mar; 30(8):1127-41. PubMed ID: 26608458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes.
    Nallani SC; Goodwin B; Buckley AR; Buckley DJ; Desai PB
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):219-29. PubMed ID: 15175893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer.
    Wu J; Deng C; Meng F; Zhang J; Sun H; Zhong Z
    J Control Release; 2017 Aug; 259():76-82. PubMed ID: 28027947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy.
    Gao X; Luo Y; Wang Y; Pang J; Liao C; Lu H; Fang Y
    Int J Nanomedicine; 2012; 7():4037-51. PubMed ID: 22888241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
    Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
    Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
    J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
    Ikezoe T; Hisatake Y; Takeuchi T; Ohtsuki Y; Yang Y; Said JW; Taguchi H; Koeffler HP
    Cancer Res; 2004 Oct; 64(20):7426-31. PubMed ID: 15492266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenografts.
    Wei H; Huang J; Yang J; Zhang X; Lin L; Xue E; Chen Z
    PLoS One; 2013; 8(3):e58133. PubMed ID: 23469265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.
    Hendrikx JJ; Lagas JS; Song JY; Rosing H; Schellens JH; Beijnen JH; Rottenberg S; Schinkel AH
    Int J Cancer; 2016 Feb; 138(3):758-69. PubMed ID: 26297509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.